Evidence map›Paper›PMID 35678393›Full record

ArticleeLife2022

Heavy isotope labeling and mass spectrometry reveal unexpected remodeling of bacterial cell wall expansion in response to drugs.

Heiner Atze, Yucheng Liang, Jean-Emmanuel Hugonnet, Arnaud Gutierrez, Filippo Rusconi, Michel Arthur

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Heiner AtzeCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité., Paris, France.ORCID 0000-0003-1497-6373
Yucheng LiangCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité., Paris, France.
Jean-Emmanuel HugonnetCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité., Paris, France.ORCID 0000-0003-4150-0944
Arnaud GutierrezRobustesse et Evolvabilité de la vie, Institut Cochin, Université de Paris, INSERM U1016, CNRS UMR 8104, Paris, France.
Filippo Rusconi *Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité., Paris, France.ORCID 0000-0003-1822-0397
Michel Arthur *Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité., Paris, France.ORCID 0000-0003-1007-636X
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faeciumR56AI045626 · NIAID · RHODE ISLAND HOSPITAL · PI RICE, LOUIS B. · 2016 to 2016
$609k
NIAID NIH HHS R56 AI045626
6 · The paper itself

Abstract

Antibiotics of the β-lactam (penicillin) family inactivate target enzymes called D,D-transpeptidases or penicillin-binding proteins (PBPs) that catalyze the last cross-linking step of peptidoglycan synthesis. The resulting net-like macromolecule is the essential component of bacterial cell walls that sustains the osmotic pressure of the cytoplasm. In

Indexed as

Peptidyl TransferasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsCell WallEscherichia coliIsotope LabelingMass SpectrometryPenicillin-Binding ProteinsPeptidoglycanAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsPenicillin-Binding ProteinsPeptidoglycanPeptidyl Transferasesantibioticscell wallE. coliinfectious diseaseL,D-transpeptidasemass spectrometrymicrobiologypeptidoglycanpeptidoglycan polymerization

Identifiers

PMID35678393
PMCPMC9249393
OpenAlexW4281907276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.